DMBT1 anticorps (AA 2025-2273)
Aperçu rapide pour DMBT1 anticorps (AA 2025-2273) (ABIN1886177)
Antigène
Voir toutes DMBT1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 2025-2273
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 2025 and 2273 of Human DMBT1
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- DMBT1 (Deleted in Malignant Brain Tumors 1 (DMBT1))
-
Autre désignation
- gp340
-
Sujet
-
Loss of sequences from human chromosome 10q has been associated with the progression of human cancers.The gene DMBT1 was originally isolated based on its deletion in a medulloblastoma cell line.DMBT1 is expressed with transcripts of 6.0, 7.5, and 8.0 kb in fetal lung and with one transcript of 8.0 kb in adult lung, although the 7.5 kb transcript has not been characterized.The DMBT1 protein is a glycoprotein containing multiple scavenger receptor cysteine-rich (SRCR) domains separated by SRCR-interspersed domains (SID).Transcript variant 2 (8.0 kb) has been shown to bind surfactant protein D independently of carbohydrate recognition.This indicates that DMBT1 may not be a classical tumor supressor gene, but rather play a role in the interaction of tumor cells and the immune system.[provided by RefSeq]
-
Poids moléculaire
- 260 kDa
-
ID gène
- 1755
-
NCBI Accession
- NM_017579, NP_060049
-
Pathways
- Activation of Innate immune Response
Antigène
-